View Cart (0 items)
Nephrology Business

C.R. Bard 3Q profit falls slightly

October 24, 2012
/ Print / Reprints /
| Share More
/ Text Size+

C.R. Bard reported  profit was $129.3 million, or $1.50 a share, down 1% from the same quarter last year. Net sales in the United States were $483.4 million, a decrease of 1% from last year.  Net sales outside the U.S. were $239.5 million, an increase of 3%.

"We delivered adjusted earnings per share at the top end of our guidance range this quarter, despite significant headwinds in the United States," said Timothy M. Ring, chairman and chief executive officer "Our international investments are shifting the mix of our portfolio to faster growing markets, which remains a key focus for us as we continue to improve our growth profile by investing in geographic and product markets with superior growth opportunities."

The company also announced it would acquire surgical sealant developer Neomend Inc.

Recent Articles by Rebecca Zumoff

You must login or register in order to post a comment.